These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
555 related articles for article (PubMed ID: 19582507)
41. Expression of HLA-G is associated with prognosis in esophageal squamous cell carcinoma. Yie SM; Yang H; Ye SR; Li K; Dong DD; Lin XM Am J Clin Pathol; 2007 Dec; 128(6):1002-9. PubMed ID: 18024326 [TBL] [Abstract][Full Text] [Related]
42. Expression level of valosin-containing protein (p97) is associated with prognosis of esophageal carcinoma. Yamamoto S; Tomita Y; Hoshida Y; Iizuka N; Kidogami S; Miyata H; Takiguchi S; Fujiwara Y; Yasuda T; Yano M; Nakamori S; Sakon M; Monden M; Aozasa K Clin Cancer Res; 2004 Aug; 10(16):5558-65. PubMed ID: 15328197 [TBL] [Abstract][Full Text] [Related]
43. [Roles of Wnt-1, beta-catenin and adenomatous polyposis coli in the differentiation and proliferation of oral squamous cell carcinoma]. Zhang WM; Gao Y Zhonghua Kou Qiang Yi Xue Za Zhi; 2005 Nov; 40(6):491-4. PubMed ID: 16329837 [TBL] [Abstract][Full Text] [Related]
44. Expression of PC cell-derived growth factor and vascular endothelial growth factor in esophageal squamous cell carcinoma and their clinicopathologic significance. Chen XY; Li JS; Liang QP; He DZ; Zhao J Chin Med J (Engl); 2008 May; 121(10):881-6. PubMed ID: 18706200 [TBL] [Abstract][Full Text] [Related]
45. Assessment of clinical outcome in patients with esophageal squamous cell carcinoma using TNM classification score and molecular biological classification. Takeno S; Noguchi T; Takahashi Y; Fumoto S; Shibata T; Kawahara K Ann Surg Oncol; 2007 Apr; 14(4):1431-8. PubMed ID: 17260107 [TBL] [Abstract][Full Text] [Related]
46. Cyclooxygenase-2 expression is related to prognosis in patients with esophageal squamous cell carcinoma. Takatori H; Natsugoe S; Okumura H; Matsumoto M; Uchikado Y; Setoyama T; Sasaki K; Tamotsu K; Owaki T; Ishigami S; Aikou T Eur J Surg Oncol; 2008 Apr; 34(4):397-402. PubMed ID: 17553653 [TBL] [Abstract][Full Text] [Related]
47. Significance of macrophage chemoattractant protein-1 expression and macrophage infiltration in squamous cell carcinoma of the esophagus. Koide N; Nishio A; Sato T; Sugiyama A; Miyagawa S Am J Gastroenterol; 2004 Sep; 99(9):1667-74. PubMed ID: 15330899 [TBL] [Abstract][Full Text] [Related]
48. An inducible short-hairpin RNA vector against osteopontin reduces metastatic potential of human esophageal squamous cell carcinoma in vitro and in vivo. Ito T; Hashimoto Y; Tanaka E; Kan T; Tsunoda S; Sato F; Higashiyama M; Okumura T; Shimada Y Clin Cancer Res; 2006 Feb; 12(4):1308-16. PubMed ID: 16489088 [TBL] [Abstract][Full Text] [Related]
49. Expression of CXCL12 and its receptor CXCR4 in esophageal squamous cell carcinoma. Sasaki K; Natsugoe S; Ishigami S; Matsumoto M; Okumura H; Setoyama T; Uchikado Y; Kita Y; Tamotsu K; Hanazono K; Owaki T; Aikou T Oncol Rep; 2009 Jan; 21(1):65-71. PubMed ID: 19082444 [TBL] [Abstract][Full Text] [Related]
50. Clinical and prognostic significance of RhoA and RhoC gene expression in esophageal squamous cell carcinoma. Faried A; Faried LS; Usman N; Kato H; Kuwano H Ann Surg Oncol; 2007 Dec; 14(12):3593-601. PubMed ID: 17896152 [TBL] [Abstract][Full Text] [Related]
51. Clinical significance of detecting mucin 1 mRNA in diagnosing occult lymph node micrometastasis in esophageal cancer patients. Liu XY; Chen G; Wang Z; Liu FY Ai Zheng; 2007 Feb; 26(2):194-9. PubMed ID: 17298752 [TBL] [Abstract][Full Text] [Related]
52. SnoN overexpression is predictive of poor survival in patients with esophageal squamous cell carcinoma. Akagi I; Miyashita M; Makino H; Nomura T; Hagiwara N; Takahashi K; Cho K; Mishima T; Takizawa T; Tajiri T Ann Surg Oncol; 2008 Oct; 15(10):2965-75. PubMed ID: 18612694 [TBL] [Abstract][Full Text] [Related]
53. [Up-regulation of HOXA13 in esophageal squamous cell carcinoma of stage IIa and its effect on the prognosis]. Yan WP; Shen LY; Gu ZD; Chen KN Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Jan; 12(1):20-3. PubMed ID: 19145497 [TBL] [Abstract][Full Text] [Related]
54. [Clinical significance of abnormal expression of Aurora-A in human esophageal squamous cell carcinoma with or without lymph node metastasis]. Shi J; Xue LY; Yin N; Lu J; Fu M; Dong LJ; Shao SJ; Tong T; Zhan QM Zhonghua Zhong Liu Za Zhi; 2010 Oct; 32(10):748-51. PubMed ID: 21163064 [TBL] [Abstract][Full Text] [Related]
55. Down-regulation of stromal caveolin-1 expression in esophageal squamous cell carcinoma: a potent predictor of lymph node metastases, early tumor recurrence, and poor prognosis. Jia Y; Wang N; Wang J; Tian H; Ma W; Wang K; Tan B; Zhang G; Yang S; Bai B; Cheng Y Ann Surg Oncol; 2014 Jan; 21(1):329-36. PubMed ID: 23982252 [TBL] [Abstract][Full Text] [Related]
56. Significance of immunohistochemical expression of cyclooxygenase-2 in squamous cell carcinoma of the esophagus. Nozoe T; Ezaki T; Kabashima A; Baba H; Maehara Y Am J Surg; 2005 Jan; 189(1):110-5. PubMed ID: 15701502 [TBL] [Abstract][Full Text] [Related]
57. Recruitment of adenomatous polyposis coli and beta-catenin to axin-puncta. Faux MC; Coates JL; Catimel B; Cody S; Clayton AH; Layton MJ; Burgess AW Oncogene; 2008 Oct; 27(44):5808-20. PubMed ID: 18591934 [TBL] [Abstract][Full Text] [Related]
58. Pretreatment plasma fibrinogen level correlates with tumor progression and metastasis in patients with squamous cell carcinoma of the esophagus. Takeuchi H; Ikeuchi S; Kitagawa Y; Shimada A; Oishi T; Isobe Y; Kubochi K; Kitajima M; Matsumoto S J Gastroenterol Hepatol; 2007 Dec; 22(12):2222-7. PubMed ID: 18031385 [TBL] [Abstract][Full Text] [Related]
59. Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas. Zheng HC; Takahashi H; Li XH; Hara T; Masuda S; Guan YF; Takano Y Hum Pathol; 2008 Jul; 39(7):1042-9. PubMed ID: 18482745 [TBL] [Abstract][Full Text] [Related]
60. CyclinD1, p53, E-cadherin, and VEGF discordant expression in paired regional metastatic lymph nodes of esophageal squamous cell carcinoma: a tissue array analysis. Luo KJ; Hu Y; Wen J; Fu JH J Surg Oncol; 2011 Sep; 104(3):236-43. PubMed ID: 21480261 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]